What were the most common adverse reactions reported over 52 weeks with Enerzair Breezhaler?

The most common adverse reactions reported over 52 weeks with Enerzair Breezhaler were asthma exacerbation (41.8%), nasopharyngitis (10.9%), upper respiratory tract infection (5.6%) and headache (4.2%).